SERA STORY: Open Payments
NPI 1336637024 · SWAINSBORO, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$293 in 16 payments from 10 companies in 2025. Trend: 2023 $188 · 2024 $295 · 2025 $293
Food & beverage: $293
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $78 |
| AstraZeneca Pharmaceuticals LP | 4 | $72 |
| Novo Nordisk Inc | 2 | $31 |
| Lilly USA, LLC | 1 | $21 |
| Abbott Laboratories | 1 | $19 |
| Exact Sciences Corporation | 1 | $17 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
| SCPHARMACEUTICALS INC. | 1 | $15 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $12 |
Products named: VRAYLAR, FARXIGA, ZEPBOUND, FREESTYLE LIBRE 3, AIRSUPRA, Cologuard Collection Kit, Wegovy, CAPLYTA.
Industry payments across GA — which companies pay providers there.
